Minoxidil + vehicle of 5% Minoxidil topical foam
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Androgenetic Alopecia
Conditions
Androgenetic Alopecia
Trial Timeline
Nov 1, 2010 → Mar 1, 2013
NCT ID
NCT01319370About Minoxidil + vehicle of 5% Minoxidil topical foam
Minoxidil + vehicle of 5% Minoxidil topical foam is a phase 2 stage product being developed by Johnson & Johnson for Androgenetic Alopecia. The current trial status is completed. This product is registered under clinical trial identifier NCT01319370. Target conditions include Androgenetic Alopecia.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01319370 | Phase 2 | Completed |
Competing Products
12 competing products in Androgenetic Alopecia
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| minoxidil | Johnson & Johnson | Phase 3 | 77 |
| 5% Minoxidil Topical Foam + Vehicle Topical Foam | Johnson & Johnson | Phase 3 | 77 |
| Cyproterone Acetate (Androcur, BAY94-8367) | Bayer | Pre-clinical | 20 |
| Clascoterone 5% solution + Vehicle solution | ICON plc. | Phase 3 | 74 |
| Clascoterone 5% solution + Vehicle solution | ICON plc. | Phase 3 | 74 |
| VDPHL01 | Veradermics | Phase 2 | 47 |
| VDPHL01 QD + Placebo + VDPHL01 BID + Placebo | Veradermics | Phase 3 | 72 |
| VDPHL01 + Placebo | Veradermics | Phase 2/3 | 60 |
| VDPHL01 + Placebo | Veradermics | Phase 3 | 72 |
| MK0906, finasteride / Duration of Treatment : 48 Weeks + Comparator : placebo (unspecified) / Duration of Treatment : 48 Weeks | Organon | Phase 3 | 72 |
| ABS-201 IV Single Dose + Placebo IV + ABS-201 SC Multiple Doses + Placebo SC Injection | AbSci | Phase 1/2 | 33 |
| ATI-50002 | Aclaris Therapeutics | Phase 2 | 44 |